CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice

Experimental Gerontology

Volumn 37, Issue 1, 2001, Pages 107-126

  Manning, B M ^a   Enioutina, E Y ^a   Visic, D M ^a   Knudson, A D ^a   Daynes, R A ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adjuvant; Aging; CpG DNA; Dendritic cell; Vaccine

Indexed keywords

ADJUVANT; ANTIGEN; DIPHTHERIA TOXOID; DNA VACCINE; OLIGODEOXYNUCLEOTIDE;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DENDRITIC CELL; DRUG FORMULATION; FEMALE; HUMORAL IMMUNITY; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; QUANTITATIVE ASSAY; REGULATORY MECHANISM; TARGET CELL; TH1 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AGING; ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; BONE MARROW CELLS; CALCITRIOL; CPG ISLANDS; DENDRITIC CELLS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS VACCINES; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; OLIGODEOXYRIBONUCLEOTIDES; TH1 CELLS; VACCINES, CONJUGATE;

ANIMALIA;

EID: 0035218374     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(01)00157-7     Document Type: Article

References (72)

1. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms
2. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
3. Enhancement by various cytokines or 2-beta-mercaptoethanol of Ia antigen expression on Langerhans cells in skin from normal aged and young mice. Effect of cyclosporine A
4. Immunogenicity and efficacy of DNA vaccines encoding influenza A proteins in aged mice
5. Efficacy of anti-influenza peptide vaccine in aged mice
6. Increased VH 11 and VH Q52 gene use by splenic B cells in old mice associated with oligoclonal expansions of CD5 + B cells
7. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice
8. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12
9. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
10. Adjuvants-a classification and review of their modes of action
11. 4 on purified influenza virus hemagglutinins in man
12. Plasmid DNA expression systems for the purpose of immunization
13. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
14. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative
15. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization
16. In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen
17. The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: Characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant
18. The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly
19. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging
20. Mucosal vaccination and immune responses in the elderly
21. Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2
22. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
23. Abnormalities of B cells and dendritic cells in SAMP1 mice
24. A toll-like receptor recognizes bacterial DNA
25. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice
26. Molecular alterations in the aging immune system
27. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
28. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
29. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
30. A novel mechanism of glucocorticoid-induced immune suppression: The inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line
31. CpG motifs as immune adjuvants
32. The biochemistry of aging
33. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon- gamma production and up-regulation of CD69 via induction of antigen- presenting cell-derived interferon type I and interleukin-12
34. Immune effects and mechanisms of action of CpG motifs
35. CpG motifs in bacterial DNA trigger direct B-cell activation
36. The role of CpG dinucleotides in DNA vaccines
37. Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells
38. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells
39. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
40. Bacterial DNA as immune cell activator
41. Increased cortisol levels and impaired cognition in human aging: Implication for depression and dementia in later life
42. Cytotoxic T cell responses to DNA vaccination: Dependence on antigen presentation via class II MHC
43. Is IgG2a a good Th1 marker in mice?
44. Aging and immune function
45. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells
46. Increasing the immunogenicity of a trivalent influenza virus vaccine with adjuvant-active nonionic block copolymers for potential use in the elderly
47. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria
48. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function
49. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines
50. T cells and aging
51. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells
52. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein
53. Glucocorticoids affect human dendritic cell differentiation and maturation
54. Surface markers and transendothelial migration of dendritic cells from elderly subjects
55. Dendritic cell survival and maturation are regulated by different signaling pathways
56. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production
57. Age-associated changes in Langerhans cells of murine oral epithelium and epidermis
58. Influenza (H1N1)-ISCOMs enhance immune responses and protection in aged mice
59. Dendritic cell responsiveness to stimulation with influenza vaccine is unimpaired in old age
60. Altered immune status in the elderly
61. Advances in vaccine adjuvants
62. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
63. Dysregulation of IL-10 production with aging: Possible linkage to the age-associated decline in DHEA and its sulfated derivative
64. Constitutive activation of NF-kappa B in an animal model of aging
65. Effect of aging on epidermal dendritic cell populations in C57BL/6J mice
66. Macrophages ingest and are activated by bacterial DNA
67. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals
68. Induction of tolerance by IL-10-treated dendritic cells
69. Increased TNF-alpha and PGI(2), but not NO release from macrophages in 18-month-old rats
70. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response
71. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response
72. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow